Advicenne (ALDVI)

Currency in EUR
0.62
0.00(0.00%)
Closed·
Advertisement
Trading near 52-week Low
ALDVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.620.65
52 wk Range
0.622.35
Key Statistics
Prev. Close
0.62
Open
0.63
Day's Range
0.62-0.65
52 wk Range
0.62-2.35
Volume
25.52K
Average Volume (3m)
96.69K
1-Year Change
-61.4907%
Book Value / Share
-1.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALDVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Advicenne News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
17/09/2026
EPS / Forecast
-- / --
Revenue / Forecast
2.88M / --
EPS Revisions
Last 90 days

Compare ALDVI to Peers and Sector

Metrics to compare
ALDVI
Peers
Sector
Relationship
P/E Ratio
213.1x−2.0x−0.3x
PEG Ratio
-0.020.00
Price/Book
−0.4x0.9x2.6x
Price / LTM Sales
1.4x7.7x3.0x
Upside (Analyst Target)
-214.4%58.2%
Fair Value Upside
Unlock14.3%7.5%Unlock

Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and safe treatments for rare renal diseases in France and internationally. It offers Sibnayal for the treatment of metabolic disorders. The company also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.

Employees
11
Market
France

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
15.00K0.10%9.54K
Other Institutional Investors
6.06M41.65%3.85M
Public Companies & Retail Investors
8.47M58.25%5.39M
Total
14.55M100.00%9.25M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bpifrance Participations SA23.41%3,405,2452,166
Cemag Invest15.25%2,217,9281,411

People Also Watch

0.7330
ALHAF
-6.03%
0.98
MAAT
-1.01%
5.68
CVXC
-1.73%
0.4950
ALVIO
-9.84%
2.525
ALTRAT
-1.17%

FAQ

What Is the Advicenne (Paris: ALDVI) Share Price Today?

The Advicenne stock price today is 0.62 EUR.

What Stock Exchange Does Advicenne (ALDVI) Trade On?

Advicenne is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Advicenne?

The stock symbol (also called a 'ticker') for Advicenne is "ALDVI."

What Is the Current Advicenne Market Capitalisation?

As of today, Advicenne (Paris: ALDVI) market cap is 9.02M EUR.

Is ALDVI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Advicenne moving averages and other technical indicators, the daily buy/sell signal for ALDVI stock is Strong Sell.

How Many Times Has Advicenne Stock Split?

Advicenne has split 0 times. (See the ALDVI stock split history page for full effective split date and price information.)

How Many Employees Does Advicenne Have?

Advicenne has 11 employees, based on their latest Companies House report.

What is the current trading status of Advicenne (Paris: ALDVI)?

As of 08/10/2026, Advicenne (ALDVI) is trading at a share price of 0.62 EUR, with a previous close of 0.62 EUR. The stock has fluctuated within a day range of 0.62 EUR to 0.65 EUR, while its 52-week range spans from 0.62 EUR to 2.35 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.